- Home
- BEAT vs FMY Comparison
BEAT vs FMY Comparison
Compare BEAT & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BEAT
- FMY
- Stock Information
- Founded
- BEAT 2015
- FMY 2005
- Country
- BEAT United States
- FMY United States
- Employees
- BEAT N/A
- FMY N/A
- Industry
- BEAT Retail: Computer Software & Peripheral Equipment
- FMY Finance/Investors Services
- Sector
- BEAT Technology
- FMY Finance
- Exchange
- BEAT Nasdaq
- FMY Nasdaq
- Market Cap
- BEAT 55.6M
- FMY 49.6M
- IPO Year
- BEAT 2021
- FMY N/A
- Fundamental
- Price
- BEAT $1.81
- FMY $12.11
- Analyst Decision
- BEAT Buy
- FMY
- Analyst Count
- BEAT 1
- FMY 0
- Target Price
- BEAT $8.00
- FMY N/A
- AVG Volume (30 Days)
- BEAT 55.5K
- FMY 10.1K
- Earning Date
- BEAT 05-13-2025
- FMY 01-01-0001
- Dividend Yield
- BEAT N/A
- FMY 6.98%
- EPS Growth
- BEAT N/A
- FMY N/A
- EPS
- BEAT N/A
- FMY N/A
- Revenue
- BEAT N/A
- FMY N/A
- Revenue This Year
- BEAT N/A
- FMY N/A
- Revenue Next Year
- BEAT N/A
- FMY N/A
- P/E Ratio
- BEAT N/A
- FMY N/A
- Revenue Growth
- BEAT N/A
- FMY N/A
- 52 Week Low
- BEAT $1.45
- FMY $10.71
- 52 Week High
- BEAT $3.48
- FMY $12.17
- Technical
- Relative Strength Index (RSI)
- BEAT 49.82
- FMY 54.68
- Support Level
- BEAT $1.78
- FMY $11.95
- Resistance Level
- BEAT $1.91
- FMY $12.24
- Average True Range (ATR)
- BEAT 0.15
- FMY 0.13
- MACD
- BEAT 0.02
- FMY 0.01
- Stochastic Oscillator
- BEAT 44.67
- FMY 66.26
About BEAT Heartbeam Inc.
HeartBeam Inc is a medical technology company primarily focusing on developing and commercializing higher resolution ambulatory Electrocardiogram ("ECG") solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The Company's ability to develop higher-resolution ECG solutions is achieved through the development of the Company's proprietary and patented Vector Electrocardiography ("VECG") technology platform. The Company has validated this technology and is seeking U.S. Food and Drug Administration ("FDA") clearance for its initial telehealth products.
About FMY First Trust Motgage Income Fund of Beneficial Interest
First Trust Mortgage Income Fund is a United States based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield and maturity.